Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Dutch Cancer Society, Cancer Research UK, National Health and Medical Research Council Australia, Cancer Australia, Italian Medicines Agency, and the Canadian Cancer Society Research Institute.
Authors
- Viet Do (ORCID: https://orcid.org/0000-0003-1386-0758)
- Henry C Kitchener (ORCID: https://orcid.org/0000-0001-5791-7838)
- Diane Provencher (ORCID: https://orcid.org/0000-0003-1902-3256)
- Alicia León‐Castillo (ORCID: https://orcid.org/0000-0003-0873-5362)
- Remi A. Nout (ORCID: https://orcid.org/0000-0001-8011-2982)
- Jeanette M. Bouma
- Tjalling Bosse (ORCID: https://orcid.org/0000-0002-6881-8437)
- Alexandra Léary (ORCID: https://orcid.org/0000-0002-2043-2244)
- Dionyssios Katsaros (ORCID: https://orcid.org/0000-0002-8267-1494)
- Mary McCormack (ORCID: https://orcid.org/0000-0002-8429-5744)
- Cathalijne Post (ORCID: https://orcid.org/0000-0003-2534-6887)
- Romerai D’Amico
- Stephanie M. de Boer (ORCID: https://orcid.org/0000-0002-8454-1597)
- Ina M. Jürgenliemk‐Schulz (ORCID: https://orcid.org/0000-0003-4911-006X)
- Ludy Lutgens (ORCID: https://orcid.org/0000-0002-2942-8858)
- Petronella B. Ottevanger (ORCID: https://orcid.org/0000-0001-8209-487X)
- Catherine Genestie (ORCID: https://orcid.org/0000-0003-0927-1985)
- Paul Bessette
- Linda Mileshkin (ORCID: https://orcid.org/0000-0001-6826-6014)
- Hans W. Nijman (ORCID: https://orcid.org/0000-0002-1821-3042)
- Cyrus Chargari (ORCID: https://orcid.org/0000-0003-0119-3695)
- Hein Putter (ORCID: https://orcid.org/0000-0001-5395-1422)
- Carien L. Creutzberg (ORCID: https://orcid.org/0000-0002-7008-4321)
- Melanie Powell (ORCID: https://orcid.org/0000-0002-9850-8181)
- Anthony Fyles (ORCID: https://orcid.org/0000-0002-3633-2483)
- Pearly Khaw (ORCID: https://orcid.org/0000-0002-1474-0881)
- Amanda Feeney
- Andrea Alberto Lissoni
- Karen Whitmarsh
Institutions
- University College Hospital (GB)
- Radboud University Nijmegen (NL)
- Barts Health NHS Trust (GB)
- Leiden University Medical Center (NL)
- Peter MacCallum Cancer Centre (AU)
- Cancer Research UK (GB)
- Institut Gustave Roussy (FR)
- Princess Margaret Cancer Centre (CA)
- Radboud University Medical Center (NL)
- University of Manchester (GB)
- University Medical Center Utrecht (NL)
- Cancer Research UK Manchester Institute (GB)
- University College London (GB)
Publication Details
- Journal
- The Lancet Oncology
- Published
- 2025-09-05
- DOI
- https://doi.org/10.1016/s1470-2045(25)00379-1
- Citations
- 18
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 37.03
Funders
- Cancer Research UK
- KWF Kankerbestrijding
- Canadian Cancer Society Research Institute
- National Health and Medical Research Council
- Agenzia Italiana del Farmaco, Ministero della Salute